Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

RNA Cancer Immunotherapy Shown Feasible in Preclinical Test

Lung cancer illustration

Tests with lab animals show synthetic viral RNA particles, encased in natural oils, can safely invoke an immune response to attack solid tumors. . . . → Read More: RNA Cancer Immunotherapy Shown Feasible in Preclinical Test

Patent Issued for Crispr-Edited Viruses in Microbiome

Crispr-Cas9

A biotechnology company developing gene-edited therapies for bacterial infections in the gut received a U.S. patent for viruses engineered as treatments. . . . → Read More: Patent Issued for Crispr-Edited Viruses in Microbiome

Stem Cell Lab Planned for Commercial Space Station

Orbital Reef

A collaboration between university researchers and a space science company is designing a stem cell research lab on a proposed commercial space station. . . . → Read More: Stem Cell Lab Planned for Commercial Space Station

Trial Underway Assessing Gut Microbiome-Cancer Links

Gut microbes

A clinical trial began collecting stool and blood samples to find connections between microbial communities in the gut and four types of solid-tumor cancer. . . . → Read More: Trial Underway Assessing Gut Microbiome-Cancer Links

Cell, mRNA Therapy Biotech Raises $165M in Early Funds

T-cells illustration

A new company, founded by university medical researchers, is developing cell therapies engineered with messenger RNA or mRNA to work inside the body. . . . → Read More: Cell, mRNA Therapy Biotech Raises $165M in Early Funds

Gut Microbes Shown to Detect Colorectal Cancer

Detect cancer scrabble

An analysis of gut bacteria and blood samples from patients indicates changes in the microbiome can provide early warnings for colorectal cancer. . . . → Read More: Gut Microbes Shown to Detect Colorectal Cancer

Precision Meds Shown Effective in Rare Cancer

Cancer on clipboard

Results from a clinical trial show patients with rare bile duct tumors respond to an experimental treatment blocking a specific cancer-causing protein. . . . → Read More: Precision Meds Shown Effective in Rare Cancer

Trial to Assess Multi-Factor Blood Test for Cancer

Blood sample vials

A clinical trial is set to begin that evaluates genomic and related data from routine blood tests to screen for cancer in real-world settings. . . . → Read More: Trial to Assess Multi-Factor Blood Test for Cancer

AI Recreates Tumor Environment for Precision Cancer Care

Breast tumor microenvironment

A bioinformatics company designed an algorithm that digitally recreates the support network for tumors from RNA sequences, to guide precise treatments for cancer patients. . . . → Read More: AI Recreates Tumor Environment for Precision Cancer Care

Patent Issued for Anti-Bacterial Viruses with Crispr Payloads

Crispr graphic

A biotechnology company received a patent for its engineered viruses to deliver gene-edited treatments to combat bacterial infections in the microbiome. . . . → Read More: Patent Issued for Anti-Bacterial Viruses with Crispr Payloads